Literature DB >> 22364972

Surgical risk and outcome of repair versus replacement for late tricuspid regurgitation in redo operation.

Shao-Wei Chen1, Feng-Chun Tsai, Feng-Chang Tsai, Yin-Kai Chao, Yao-Kuang Huang, Jaw-Ji Chu, Pyng-Jing Lin.   

Abstract

BACKGROUND: Late tricuspid regurgitation after previous cardiac operation remains controversial in terms of when to repair and who will benefit. We reviewed our surgical experiences and stratified the risk factors for death and morbidity.
METHODS: From September 2005 to September 2010, 77 consecutive patients (36 men [47%]) underwent redo open heart operations with the tricuspid valve (TV) procedure. Their mean age was 56±13 years (range, 27 to 83 years). TV repair was performed in 44 (57%) and TV replacement in 33 (43%): 23 received bioprostheses; 10 received mechanical prostheses.
RESULTS: Fourteen (18%) patients died after the operation. Risk factors of hospital death by multivariate analysis were age (>65 years), preoperative renal insufficiency (creatinine>2 mg/dL), and preoperative severe liver cirrhosis (Child classification C). Compared with the group that underwent TV repair, those who underwent TV replacement tended to have had previous TV operations (46% vs 9%; p<0.001) and preoperative Child class C liver cirrhosis (21% vs 2%; p=0.018). Although in-hospital mortality was insignificant (24% vs 14%; p=0.232), postoperative morbidities of tracheotomy, gastrointestinal bleeding, and late death were higher in the replacement group.
CONCLUSIONS: Patients who had previous TV operations and preoperative severe liver cirrhosis were more likely to undergo TV replacement in tricuspid reoperations. Compared with patients in the repair group, patients in the replacement group had higher morbidities and low late survival. Earlier intervention, before decompensated heart failure occurs, is warranted to improve the outcome.
Copyright © 2012 The Society of Thoracic Surgeons. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2012        PMID: 22364972     DOI: 10.1016/j.athoracsur.2011.11.057

Source DB:  PubMed          Journal:  Ann Thorac Surg        ISSN: 0003-4975            Impact factor:   4.330


  5 in total

1.  Simplified model for end-stage liver disease score predicts mortality for tricuspid valve surgery.

Authors:  Kazumasa Tsuda; Masaaki Koide; Yoshifumi Kunii; Kazumasa Watanabe; Satoshi Miyairi; Yuko Ohashi; Takashi Harada
Journal:  Interact Cardiovasc Thorac Surg       Date:  2013-02-12

2.  Efficiency of different annuloplasty in treating functional tricuspid regurgitation and risk factors for recurrence.

Authors:  Yiyun Lin; Zhinong Wang; Jia He; Zhiyun Xu; Jian Xiao; Yufeng Zhang; Hao Peng
Journal:  Int J Cardiol Heart Vasc       Date:  2014-11-07

3.  A case report: intravalvular regurgitation during percutaneous valve-in-ring implantation due to eccentric bulging of a balloon-expandable valve in a patient with severe right heart failure.

Authors:  Muhammed Gerçek; René Schramm; Lech Paluszkiewicz; Tanja Katharina Rudolph
Journal:  Eur Heart J Case Rep       Date:  2019-10-17

4.  Isolated Reoperative Tricuspid Valve Surgery: Outcomes and Risk Assessment.

Authors:  Tahir I Mohamed; Omar J Baqal; Abdulaziz A Binzaid; Hussam T AlHennawi; Abdulrahman R Barakeh; Omar M Mrayati; Aly M Alsanei
Journal:  J Saudi Heart Assoc       Date:  2022-01-05

5.  Late Outcomes of Valve Repair Versus Replacement in Isolated and Concomitant Tricuspid Valve Surgery: A Nationwide Cohort Study.

Authors:  Wang-Kin Wong; Shao-Wei Chen; An-Hsun Chou; Hsiu-An Lee; Yu-Ting Cheng; Feng-Chun Tsai; Kuang-Tso Lee; Victor Chien-Chia Wu; Chun-Li Wang; Shang-Hung Chang; Pao-Hsien Chu
Journal:  J Am Heart Assoc       Date:  2020-04-17       Impact factor: 5.501

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.